Octave Specialty Group (OSG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 May, 2026Executive summary
Completed sale of legacy financial guarantee business for $420 million in Q3 2025, removing $6.2 billion in liabilities and enabling exclusive focus on specialty insurance distribution and underwriting.
Company rebranded and streamlined leadership to four executive officers, aligning with a new specialty P&C platform strategy.
Board recommends voting for all proxy proposals, including director elections, executive compensation, auditor ratification, and the 2026 Incentive Compensation Plan.
Voting matters and shareholder proposals
Proposals include election of directors, advisory vote on executive compensation (say-on-pay), ratification of Ernst & Young LLP as auditor, and approval of the 2026 Incentive Compensation Plan.
Board unanimously recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of 7 members, 6 of whom are independent, with diverse backgrounds in finance, insurance, and governance.
Separate Chairman and CEO roles, annual director elections, and no classified board structure.
All directors actively engaged and attend meetings.
Latest events from Octave Specialty Group
- Insurance Distribution revenue up 92%, total revenue up 66%, and adjusted EBITDA surged.OSG
Q1 20267 May 2026 - Shareholders to vote on board, compensation, auditor, and new incentive plan after major transformation.OSG
Proxy filing10 Apr 2026 - Board recommends approval of all annual meeting proposals, including director elections and compensation.OSG
Proxy filing10 Apr 2026 - Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026 - Revenue up 27% and P&C premium up 70%, but net loss widened on higher expenses.OSG
Q1 20257 Jan 2026 - Record premium growth and margin gains offset by $548M net loss from legacy business sale.OSG
Q4 202423 Dec 2025